The Patent Trial and Appeal Board’s conclusion following inter partes review that a cellular communications patent directed to frequency hopping owned by Intellectual Ventures I LLC was invalid and anticipated was not supported by substantial evidence, the U.S. Court of Appeals for the Federal Circuit had held. Among other things, the Board erred in invalidating…

The federal district court in Chicago did not err in dismissing a patent infringement suit filed by Maxon, LLC against several smart television manufacturers on the ground that the asserted patents—describing an electronic means of increasing user control over subscription entertainment content for smart TVs—were invalid as directed to an abstract idea that lacked an…

Two final decisions of the Patent Trial and Appeal Board—each finding that certain apparatus claims of a wireless communication network owned by DSS Technology Management were invalid as obvious—have been reversed by the U.S. Court of Appeals for the Federal Circuit, because the Board failed to provide a sufficient explanation for its findings, and a…

Substantial evidence supported the Patent Trial and Appeal Board’s finding that an inter partes review petitioner failed to show that a patent owned by Thales Visionix—claiming a method for tracking motion relative to a moving platform—was not obvious over a prior art patent combined with two additional references, the U.S. Court of Appeals for the…

The federal district court in Wilmington, Delaware, did not err in finding that several claims of a patent for preparing a stable formulation of the antibiotic compound ertapenem owned by Merck Sharp & Dohme were invalid as obvious, the U.S. Court of Appeals for the Federal Circuit has held. Substantial record evidence supported the district…

Following inter partes review of several claims of a patent directed to a trigger/seal mechanism for a beverage container, the Patent Trial and Appeal Board properly applied the broadest reasonable in construing a connection limitation disclosed in the challenged claims, the U.S. Court of Appeals for the Federal Circuit has decided. The Board’s construction was…

The Patent Trial and Appeal Board’s construction of the term “body” disclosed in multiple claims of a downhole drilling tool patent has been reversed by the U.S. Court of Appeals for the Federal Circuit as unreasonably overbroad and contrary to descriptions in the patent’s specification. The Board’s rejection of the challenged claims following inter partes…

The Patent Trial and Appeal Board’s construction of a key claim term in a patent directed to a method for fabricating a self-aligned contact hole in a semiconductor circuit was overbroad in light of the actual claim language and specification, the U.S. Court of Appeals for the Federal Circuit has held. Because a prior art…

The Patent Trial and Appeal Board did not err in instituting Covered Business Method (“CBM”) review and finding several claims of a financing method patent owned by Credit Acceptance Corporation (“CAC”) to be directed to a patent-ineligible abstract idea, the U.S. Court of Appeals for the Federal Circuit has ruled. The Board correctly rejected CAC’s…

The federal district court in Wilmington, Delaware, did not abuse its discretion in finding that Bayer CropScience’s infringement suit against agrochemical rival Dow AgroSciences over soybean gene technology qualified as an “exceptional case” warranting an award of attorney fees under Section 285 of the Patent Act, the U.S. Court of Appeals for the Federal Circuit…